INmune Bio Inc reports results for the quarter ended in June - Earnings Summary

Inmune Bio

07/08/2023 23:01

* INmune Bio Inc  INMB.OQ  reported a quarterly adjusted
loss
of 36 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 40 cents per share.
    * Revenue rose 187.5% to $46.00 thousand from a year ago;
analysts
expected zero. 
    * INmune Bio Inc's reported EPS for the quarter was a loss
of 36
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * INmune Bio Inc shares had fallen by 5.2% this quarter and
gained 35.8% so far this year.
    * The company reported a quarterly loss of $6.5 million.
    * Wall Street's median 12-month price target for INmune Bio
Inc is
$16.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 10:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.40          -0.36          Beat
 Mar. 31 2023      -0.02          -0.36          Missed
 Dec. 31 2022      -0.48          -0.32          Beat
 Sep. 30 2022      -0.52          -0.43          Beat